• 897 Citations
  • 13 h-Index
1977 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

For more than 38 years, I have been involved in the field of gerontology and health services management. My research has been sponsored by grants from the Center for Medicare and Medicaid Innovation, National Institutes of Health, the National Science Foundation, the Administration on Aging, and various foundations. I am the Principal Investigator for the Texas Alzheimer’s Research Consortium (TARC) at UNTHSC. TARC is a state-funded collaboration between five of the state’s leading medical research institutions to improve early diagnosis, treatment, and prevention of Alzheimer’s disease.

Education/Academic qualification

PhD in Sociology, Wayne State University

Award Date: 1 Jan 2002

MS in Sociology, Wayne State University

Award Date: 1 Jan 2001

BS in Management, Wayne State University

Award Date: 1 Jan 2000

Fingerprint Dive into the research topics where Thomas Fairchild is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

  • 897 Citations
  • 13 h-Index
  • 21 Article
  • 1 Comment/debate

Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

Alzheimer Disease Genetics Consortium (ADGC), The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE) & Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES), 1 Sep 2019, In : Nature Genetics. 51, 9, p. 1423-1424 2 p.

Research output: Contribution to journalComment/debate

Open Access
  • Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Alzheimer Disease Genetics Consortium (ADGC), The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), & Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES), 1 Mar 2019, In : Nature Genetics. 51, 3, p. 414-430 17 p.

    Research output: Contribution to journalArticle

  • 90 Scopus citations

    Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

    International Genomics of Alzheimer's Project (IGAP), ARUK Consortium & GERAD/PERADES, CHARGE, ADGC, EADI, 1 Jan 2018, In : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 10, p. 595-598 4 p.

    Research output: Contribution to journalArticle

  • Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging

    Texas Alzheimer's Research, Care Consortium, Aug 2018, In : American Journal of Geriatric Psychiatry. 26, 8, p. 835-846 12 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations

    Sex-specific association of apolipoprotein e with cerebrospinal fluid levels of tau

    Alzheimer's Disease Genetics Consortium and the Alzheimer's Disease Neuroimaging Initiative, 1 Aug 2018, In : JAMA Neurology. 75, 8, p. 989-998 10 p.

    Research output: Contribution to journalArticle

  • 30 Scopus citations